Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
2.
Pediatr Neurosurg ; 53(5): 311-316, 2018.
Article in English | MEDLINE | ID: mdl-30110687

ABSTRACT

Primary central nervous system lymphoma (PCNSL) is rare in children with immunocompromise as an important risk factor. A 7-year-old girl with unspecified T-cell immunodeficiency presented with left-sided weakness and was found to have a right-sided frontal lobe mass on imaging. The mass was resected; histopathology and molecular studies evidenced diffuse large B-cell lymphoma. Prior chest imaging had revealed left upper lobe mass, and repeat chest imaging revealed multiple pulmonary nodules, initially concerning for metastasis. Video-assisted thoracoscopic surgical wedge resection of the lung mass was performed; the molecular profile was distinct from the PCNSL, suggesting synchronous de novo lymphomagenesis of brain and pulmonary primaries.


Subject(s)
Central Nervous System Neoplasms/pathology , Central Nervous System Neoplasms/surgery , Lung Neoplasms/pathology , Lung Neoplasms/surgery , Lymphoma, Large B-Cell, Diffuse/pathology , Neoplasms, Multiple Primary/pathology , Neoplasms, Multiple Primary/surgery , Central Nervous System Neoplasms/diagnostic imaging , Child , Diagnosis, Differential , Female , Frontal Lobe , Humans , Lung Neoplasms/diagnostic imaging , Lymphoma, Large B-Cell, Diffuse/diagnostic imaging , Lymphoma, Large B-Cell, Diffuse/surgery , Magnetic Resonance Imaging , Neoplasms, Multiple Primary/diagnostic imaging , Thoracic Surgery, Video-Assisted/methods
3.
Am J Clin Pathol ; 150(5): 393-405, 2018 Oct 01.
Article in English | MEDLINE | ID: mdl-30052721

ABSTRACT

OBJECTIVES: To assess bone marrow (BM) sampling in academic medical centers. METHODS: Data from 6,374 BM samples obtained in 32 centers in 2001 and 2011, including core length (CL), were analyzed. RESULTS: BM included a biopsy (BMB; 93%) specimen, aspirate (BMA; 92%) specimen, or both (83%). The median (SD) CL was 12 (8.5) mm, and evaluable marrow was 9 (7.6) mm. Tissue contraction due to processing was 15%. BMB specimens were longer in adults younger than 60 years, men, and bilateral, staging, and baseline samples. Only 4% of BMB and 2% of BMB/BMA samples were deemed inadequate for diagnosis. BM for plasma cell dyscrasias, nonphysician operators, and ancillary studies usage increased, while bilateral sampling decreased over the decade. BM-related quality assurance programs are infrequent. CONCLUSIONS: CL is shorter than recommended and varies with patient age and sex, clinical circumstances, and center experience. While pathologists render diagnoses on most cases irrespective of CL, BMB yield improvement is desirable.


Subject(s)
Bone Marrow Diseases/pathology , Bone Marrow/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Biopsy, Large-Core Needle , Bone Marrow Diseases/diagnosis , Bone Marrow Examination/standards , Canada , Child , Child, Preschool , Cross-Sectional Studies , Female , Humans , Infant , Male , Middle Aged , Retrospective Studies , United States , Young Adult
4.
Lab Med ; 49(3): 226-230, 2018 Jul 05.
Article in English | MEDLINE | ID: mdl-29529240

ABSTRACT

BACKGROUND: Thromboelastography (TEG) has become the standard of care in liver-transplant surgery to identify real-time abnormalities in the coagulation cascade. To our knowledge, no studies have been performed to measure the intrasubject reproducibility of TEG parameters in cirrhotic patients. OBJECTIVE: To perform a validation study to determine the reproducibility of TEG in cirrhosis. METHODS: We recruited 30 patients with stable cirrhosis and tested 25 of them. Two blood specimens were drawn 1 hour apart; we measured the TEG parameters R time, K time, angle, maximum amplitude (MA), and functional fibrinogen (FF), along with conventional coagulation parameters. Reproducibility was assessed using the intraclass coefficient test. The TEG parameters were then compared with conventional coagulation test results. RESULTS: The K time, angle, MA, and FF results showed excellent reproducibility (r > 0.7; P <.001). Platelets and fibrinogen correlated with MA and K time; prothrombin time (PT) and activated partial thromboplastin time (aPTT) were inversely correlated with MA. CONCLUSION: All parameters were reproducible when measured 1 hour apart. TEG may be suitable to investigate coagulation characteristics in patients with clinically stable cirrhosis; however, further studies are needed in patients with more advanced cirrhosis, in whomblood product use may be more prevalent.


Subject(s)
Liver Cirrhosis , Thrombelastography/standards , Female , Humans , Liver Cirrhosis/blood , Liver Cirrhosis/physiopathology , Liver Transplantation , Male , Middle Aged , Reproducibility of Results
6.
Int Surg ; 100(1): 142-54, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25594655

ABSTRACT

Kidney transplantation alone in clinically compensated patients with cirrhosis is not well documented. Current guidelines list cirrhosis as a contraindication for kidney transplantation alone. This is an Institutional Review Board-approved retrospective study. We report our experience with a retrospective comparison between transplants in hepatitis C virus-positive (HCV(+)) patients without cirrhosis and HCV(+) patients with cirrhosis. All of the patients were followed for at least a full 3-year period. All of the deaths and graft losses were recorded and analyzed using Kaplan-Meier methodology. One- and three-year cumulative patient survival rates for noncirrhotic patients were 91% and 82%, respectively. For cirrhotic patients, one- and three-year cumulative patient survival rates were 100% and 83%, respectively (P = NS). One- and three-year cumulative graft survival rates censored for death were 94% and 81%, and 95% and 82% for the noncirrhosis and cirrhosis groups, respectively (P = NS). Comparable patient and allograft survival rates were observed when standard kidney allograft recipients were analyzed separately. This study is the longest follow-up document in the literature showing that HCV(+) clinically ompensated patients with cirrhosis may undergo kidney transplantation alone as a safe and viable practice.


Subject(s)
Hepatitis C, Chronic/complications , Kidney Failure, Chronic/surgery , Kidney Transplantation , Liver Cirrhosis/complications , Adult , Aged , Case-Control Studies , Female , Follow-Up Studies , Graft Survival , Hepatitis C, Chronic/mortality , Humans , Kidney Failure, Chronic/complications , Kidney Failure, Chronic/mortality , Liver Cirrhosis/mortality , Liver Cirrhosis/virology , Male , Middle Aged , Retrospective Studies , Treatment Outcome
7.
Exp Clin Transplant ; 13(1): 86-91, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25343464

ABSTRACT

New information has demonstrated that there are few long-term disease-free survivors after a liver transplant for neuroendocrine tumors. All studies have limited follow-up to 10 years after a transplant. We present the case of a recurrent metastatic carcinoid in a patient 16 years after an orthotopic liver transplant. The subject initially presented with worsening chronic diarrhea, hypoglycemia, and confusion with massive hepatomegaly. The postoperative pathology report showed 80% to 90% of the liver tissue replaced by biopsy-proven synaptophysin-positive intrahepatic tumor with neuroendocrine differentiation. At the time of his liver transplant, he also underwent a distal pancreatectomy and splenectomy. Nuclear medicine tumor location studies, ultrasound, and computed tomography studies were performed at regular yearly intervals for 8 years on follow-up. Sixteen years after his orthotopic liver transplant, a retroperitoneal mass was detected showing neuroendocrine differentiation. Older studies focusing on an orthotopic liver transplant for highlighted clinical features would positively predict long-term survival. Older studies found the following features to be predictive of long-term survival in liver transplant for neuroendocrine tumors: age < 55 years, < 50% replacement of liver with metastatic neoplastic tissue and carcinoid type. These features were identified on multiple studies as positive predictors of disease-free survival. These studies were limited to, at most, 10-year follow-up. Newer studies have examined molecular features such as expression of E-cadherin and Ki-67 as positive predictors of long-term survival. However, no study has determined the full natural history of these tumors and for how long these patients should be followed. This anecdotal report highlights that late recurrence can occur.


Subject(s)
Kidney Neoplasms/secondary , Liver Neoplasms/secondary , Liver Neoplasms/surgery , Liver Transplantation , Neuroendocrine Tumors/secondary , Neuroendocrine Tumors/surgery , Pancreatic Neoplasms/pathology , Biomarkers, Tumor/analysis , Biopsy , Humans , Immunohistochemistry , Kidney Neoplasms/surgery , Liver Neoplasms/chemistry , Lymphatic Metastasis , Male , Middle Aged , Nephrectomy , Neuroendocrine Tumors/chemistry , Pancreatectomy , Pancreatic Neoplasms/chemistry , Pancreatic Neoplasms/surgery , Time Factors , Tomography, X-Ray Computed , Treatment Outcome
8.
J Clin Rheumatol ; 19(6): 348-50, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23965475

ABSTRACT

The objective of this study was to report an unusual case of primary antiphospholipid syndrome (APS)-associated severe necrotizing pancreatitis. Since the APS was first recognized in the 1980s, a number of manifestations of the disorder have been described. We report primary APS presenting as severe necrotizing pancreatitis. This is the first such case to date that fulfills the revised Sapporo classification criteria. A 38-year-old previously healthy woman presented with new-onset hypertensive emergency and acute kidney injury. She subsequently developed severe epigastric pain attributable to necrotizing pancreatitis and extensive splenic infarcts. Biopsies of both the pancreas and kidney revealed thrombotic microangiopathy. Her lupus anticoagulant was positive on both weeks 1 and 12 of her disease course. A diagnosis of primary APS was made. Despite 6 months of aggressive care, she died of sepsis.


Subject(s)
Antiphospholipid Syndrome/complications , Antiphospholipid Syndrome/diagnosis , Pancreatitis, Acute Necrotizing/diagnosis , Pancreatitis, Acute Necrotizing/etiology , Adult , Antiphospholipid Syndrome/pathology , Biopsy , Fatal Outcome , Female , Humans , Kidney/pathology , Pancreas/pathology , Pancreatitis, Acute Necrotizing/pathology
9.
Am J Cardiovasc Dis ; 3(3): 170-4, 2013.
Article in English | MEDLINE | ID: mdl-23991352

ABSTRACT

UNLABELLED: The Middle East represents an attractive area for young individuals to seek employment, where they are exposed to numerous environmental conditions. The pursuit of a better standard of living has driven hundreds to the Middle East over the recent decades. This influx has also resulted in a predisposition to premature coronary artery disease (CAD). The aim of this study was to provide an overview of the risk factors in patients younger than 45 years, presenting with acute myocardial infarction (AMI). Out of the 148 patients analyzed, 137 were males and 11 females. 119 were from South Asia and 29 were Arabs. Their mean age was 36 ± 4.2 years. Smoking was the most prevalent risk factor in both groups at 67.6%. This was followed by hypertension, family history of CAD, hyperlipidemia and Diabetes mellitus. There was no significant difference in the clinical risk factor profile between these two groups. ST elevation myocardial infarction (STEMI) was noted in 67.6%, while 32.4% patients suffered a Non ST elevation myocardial infarction (NSTEMI). 84.5% received coronary stents, 8.8% had lone thrombus aspiration or balloon angioplasty only, while the rest were treated by conservative medical management or referred for coronary artery bypass surgery. CONCLUSION: There is no significant difference in the CAD risk profile between young South Asian and Arab patients. Preventive strategies focused on risk factor reduction, especially smoking cessation, should be implemented to protect young adults in the most productive years of their life.

10.
Arch Pathol Lab Med ; 137(2): 270-4, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23368870

ABSTRACT

CONTEXT: As demand for organs to treat end-stage liver disease increases, donor livers once deemed only marginally suitable for donation are being considered for transplantation. Pathologists are increasingly being asked to evaluate these livers for acceptability. This article provides guidelines for frozen section evaluation of livers for transplantation. OBJECTIVE: This article concentrates on the histopathologic features of transplant suitability with appropriate clinicopathologic correlation for the practicing pathologist. Recommendations for proper handling and sampling of tissue are discussed. Relative and absolute contraindications as well as artifacts and benign conditions are emphasized. DATA SOURCES: Sources include a compilation of the authors' experiences in academic and community liver transplantation centers. In addition, relevant medical literature was reviewed, as well as Web sites specializing in organ transplantation, such as Transplant Pathology Internet Services and the Organ Procurement and Transplantation Network. CONCLUSIONS: Malignancy and extensive necrosis in the liver are absolute contraindications to transplantation. Evaluation of macrosteatosis, fibrosis, hepatitis, and necrosis depends on the severity of disease and correlation with the clinical situation. Donor age of greater than 60 years does not preclude transplantation. Artifacts and benign conditions need to be understood to prevent wastage of precious organs and to ensure that an appropriate organ is provided for the recipient.


Subject(s)
Liver Transplantation , Tissue Donors , Biopsy , Contraindications , Donor Selection , Fatty Liver/pathology , Focal Nodular Hyperplasia/pathology , Frozen Sections , Hepatitis C, Chronic/pathology , Humans , Intraoperative Period , Liver/pathology , Liver Cirrhosis/pathology , Liver Neoplasms/pathology , Liver Transplantation/adverse effects , Liver Transplantation/pathology , Living Donors , Necrosis , Pathology, Surgical , Referral and Consultation , Risk Factors , Siderosis/pathology , Tissue and Organ Harvesting
11.
J Surg Res ; 179(1): e1-e12, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22480830

ABSTRACT

Thermal plasma is a valued tool in surgery for its coagulative and ablative properties. We suggested through in vitro studies that nonthermal plasma can sterilize tissues, inactive pathogens, promote coagulation, and potentiate wound healing. The present research was undertaken to study acute toxicity in porcine skin tissues. We demonstrate that floating electrode-discharge barrier discharge (FE-DBD) nonthermal plasma is electrically safe to apply to living organisms for short periods. We investigated the effects of FE-DBD plasma on Yorkshire pigs on intact and wounded skin immediately after treatment or 24h posttreatment. Macroscopic or microscopic histological changes were identified using histological and immunohistochemical techniques. The changes were classified into four groups for intact skin: normal features, minimal changes or congestive changes, epidermal layer damage, and full burn and into three groups for wounded skin: normal, clot or scab, and full burn-like features. Immunohistochemical staining for laminin layer integrity showed compromise over time. A marker for double-stranded DNA breaks, γ-H2AX, increased over plasma-exposure time. These findings identified a threshold for plasma exposure of up to 900s at low power and <120s at high power. Nonthermal FE-DBD plasma can be considered safe for future studies of external use under these threshold conditions for evaluation of sterilization, coagulation, and wound healing.


Subject(s)
Plasma Gases/therapeutic use , Skin/physiopathology , Wounds, Penetrating/physiopathology , Wounds, Penetrating/therapy , Animals , Female , Histones/metabolism , Laminin/metabolism , Models, Animal , Pilot Projects , Skin/metabolism , Swine , Time Factors , Treatment Outcome , Wound Healing/physiology , Wounds, Penetrating/metabolism
12.
Exp Clin Transplant ; 9(2): 105-12, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21453227

ABSTRACT

OBJECTIVES: The rate of hepatitis C virus recurrence after donation after cardiac death liver transplant is not clearly defined. MATERIALS AND METHODS: This is a retrospective review of 39 donations after cardiac death-liver transplant recipients. Biopsies were performed at 6, 12, 24, and 36 months for all hepatitis C virus positive donation after cardiac death recipients. RESULTS: The 6-, 12-, 24-, and 36-month severe hepatitis C virus recurrence rates were 60%, 73%, 87%, and 94%. A histologic comparison group of 26 long-surviving hepatitis C virus positive donation after neurologic death recipients had severe hepatitis C virus recurrence 27%, 31%, 42%, and 52% of the time. Six of the 19 hepatitis C virus donation after cardiac death patients developed cirrhosis at a median of 56 months (range, 14-119 months). There was no significant 3-year allograft and patient survival difference between hepatitis C virus and nonhepatitis C virus donation after cardiac death recipients. The factors most associated with decreased survival in the entire cohort included biliary and vascular complications. Organs procured by our institution's attending surgeons were associated with a better 3-year allograft survival. CONCLUSIONS: Severe hepatitis C virus recurrence was nearly universal but did not lead to increased graft loss when compared with nonhepatitis C virus donation after cardiac death at 3 years. These data may justify early interferon treatment in these at-risk patients.


Subject(s)
Death , Hepacivirus/isolation & purification , Hepatitis C/epidemiology , Liver Transplantation , Liver/virology , Severity of Illness Index , Tissue Donors , Adult , Aged , Biopsy , Female , Graft Survival/physiology , Humans , Incidence , Kaplan-Meier Estimate , Liver/pathology , Liver Transplantation/physiology , Male , Middle Aged , Recurrence , Retrospective Studies , Risk Factors
14.
Pharmacotherapy ; 30(9): 954, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20812435

ABSTRACT

Careful interpretation of tacrolimus levels is essential to ensure optimal immunosuppressive therapy while avoiding toxicity. Interference with tacrolimus assays may be an underreported event that has the potential to result in negative patient outcomes through unnecessary modifications of therapy. We describe a 55-year-old liver transplant recipient who had falsely elevated tacrolimus levels that led to the eventual disruption of his immunosuppressive therapy and subsequent rejection of his allograft.Although his increased tacrolimus levels did not correlate with clinical signs and symptoms of tacrolimus toxicity, interruption of therapy in this patient was supported by an acute infection and a slight elevation in serum creatinine concentration. Tacrolimus levels were analyzed by using an antibody conjugated magnetic immunoassay method, and levels as high as 79.7 ng/ml were observed, despite discontinuation of tacrolimus. We conducted an evaluation for assay interference by using an alternative assay method(microparticle enzyme immunoassay), by testing plasma samples that were not hemolyzed, and by analyzing levels of an unrelated drug that uses the same technology as the initial tacrolimus assay. beta-galactosidase antibodies were ultimately confirmed as the cause of the immunoassay interference. Inpatients receiving tacrolimus, spuriously high tacrolimus levels should be carefully evaluated, and drastic adjustments to therapy should be made only within the context of clinical toxicity.


Subject(s)
Antibodies/blood , Immunosuppressive Agents/blood , Liver Transplantation , Tacrolimus/blood , beta-Galactosidase/immunology , False Positive Reactions , Graft Rejection , Humans , Immunoassay , Immunoenzyme Techniques , Immunosuppressive Agents/therapeutic use , Male , Middle Aged , Tacrolimus/therapeutic use
16.
Eur Spine J ; 19 Suppl 2: S200-2, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20229119

ABSTRACT

Fat embolism after long bone and pelvic fractures as well as orthopedic interventions is a well-documented phenomenon, but it is highly unusual after isolated vertebral fractures. We report a case of fatal fat embolism in a 78-year-old man after an isolated vertebral compression fracture with no related orthopedic intervention. A high index of suspicion is necessary for early diagnosis and successfully treating this unusual complication.


Subject(s)
Embolism, Fat/etiology , Embolism, Fat/pathology , Fractures, Compression/complications , Fractures, Compression/pathology , Lung/pathology , Thoracic Vertebrae/pathology , Aged , Embolism, Fat/diagnostic imaging , Fatal Outcome , Fractures, Compression/diagnostic imaging , Humans , Lung/physiopathology , Male , Radiography , Thoracic Vertebrae/diagnostic imaging , Thoracic Vertebrae/injuries
17.
Ann Diagn Pathol ; 12(3): 212-6, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18486899

ABSTRACT

Combination of the splenic marginal zone B-cell lymphoma (SMZL) and classical Hodgkin lymphoma (cHL) is extremely rare. We report a unique case with concurrent SMZL and cHL. The patient was a 63-year-old man who presented with fatigue and anemia, showing a splenomegaly and retroperitoneal lymphadenopathy. A splenectomy revealed monotonous marginal zone lymphocytic infiltrates and numerous large Reed-Sternberg-like cells. Flow cytometry revealed a kappa light-chain-restricted CD5 (-), CD23 (-) B-cell population. DNA polymerase chain reaction analysis confirmed the presence of clonal rearrangement of the immunoglobulin heavy-chain gene. Immunohistochemical studies revealed that the large atypical cells were CD30 (+), CD15 (weakly +), CD20 (-), CD45 (-), Pax5 (weakly +), BOB.1 (-), and Oct2 (-), indicating the coexistence of SMZL with cHL. After the chemotherapy, the patient achieved a clinical/radiologic remission, whereas cHL was detected in liver and bone marrow subsequently. The case indicates that both components of lymphoma can present concurrently as a composite form of lymphoma and both need to be treated adequately.


Subject(s)
Hodgkin Disease/pathology , Lymphoma, B-Cell, Marginal Zone/pathology , Neoplasms, Second Primary/pathology , Splenic Neoplasms/pathology , Antigens, CD/analysis , B-Lymphocytes/chemistry , B-Lymphocytes/pathology , Combined Modality Therapy , Gene Rearrangement, B-Lymphocyte, Heavy Chain/genetics , Hodgkin Disease/genetics , Hodgkin Disease/therapy , Humans , Lymphatic Diseases , Lymphoma, B-Cell, Marginal Zone/genetics , Lymphoma, B-Cell, Marginal Zone/therapy , Male , Middle Aged , Reed-Sternberg Cells/pathology , Remission Induction , Splenic Neoplasms/genetics , Splenic Neoplasms/therapy , Splenomegaly
18.
Anal Quant Cytol Histol ; 29(5): 333-8, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17987814

ABSTRACT

OBJECTIVE: To demonstrate the unique morphologic and phenotypic features observed in cases of T-cell lymphomas presenting as effusions. STUDY DESIGN: Cytologic slides and flow cytometric histograms of 8 cases of body fluids with T-cell lymphoma were retrospectively reviewed. Morphologic features, flow cytometric histograms and immunophenotypes of the cells were evaluated. RESULTS: Three of the 8 cases showed 1 or more of the following: intermediate-to-large cells with an increased nuclear-cytoplasmic ratio, finely granular or vacuolated cytoplasm and round or convoluted vesicular nuclei with a prominent single or multiple nucleoli. Flow cytometric studies of these 3 cases showed an abnormal scatter pattern in the myelomonocytic region of the histograms. Phenotypic analysis revealed variable expression of a T-cell phenotype. The remaining cases showed the conventional morphologic and flow cytometric features of a T-cell lymphoma. CONCLUSION: Morphologic alterations of neoplastic T-cells in body fluids can result in a variety of potentially incorrect diagnoses. The unusual flow cytometric histogram can serve as a useful clue for the diagnosis of T-cell lymphoma in body fluids but could be a potential pitfall for a false negative. Detailed cytologic evaluation combined with flow cytometric study can improve diagnostic accuracy.


Subject(s)
Cytodiagnosis , Lymphoma, T-Cell/pathology , Aged , Body Fluids/cytology , Flow Cytometry , Humans , Immunohistochemistry , Male , Middle Aged , Phenotype
SELECTION OF CITATIONS
SEARCH DETAIL